-+ 0.00%
-+ 0.00%
-+ 0.00%
Median Technologies Plans to Present Emphysema Study in Lung Cancer Patients at ESMO 2026
Share
Listen to the news
Median Technologies Plans to Present Emphysema Study in Lung Cancer Patients at ESMO 2026
  • Median Technologies will present research on emphysema prevalence in non-small cell lung cancer at ESMO 2026, Oct. 23-27, in Madrid.
  • An Oct. 25 session will examine implementation of RANO 2.0 in central imaging review for neuro-oncology trials.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Median Technologies SA published the original content used to generate this news brief via Business Wire (Ref. ID: 202610211145BIZWIRE_USPR_____20261021_BW543304) on October 21, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending